Business
Press Release Oct 28 2021
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 28, 2021, titled "Sun Pharma s PrILUMYA (tildrakizumab injection)now available to help Canadians living with moderate-to-severe plaque psoriasis".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 28, 2021, titled \"Sun Pharma s PrILUMYA (tildrakizumab injection)now available to help Canadians living with moderate-to-severe plaque psoriasis\". View Attachment","length":435,"tagName":"div"}]